Health Care: Drugs

Sanofi SA (SNY: NYSE)

$42.7 n/a | n/a%
02/24/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 36.69B 38.11B 38.91B 43.21B
Cost of Sales 11.31B 9.60B 10.98B 10.68B
Gross Operating Profit 25.38B 28.51B 27.93B 32.53B
Selling, General, and Administrative Expenses 10.54B 10.76B 10.44B 11.31B
Research & Development 5.47B 5.56B 5.68B 6.36B
Operating Income before D & A (EBITDA) 9.37B 12.20B 11.82B 14.86B
Depreciation & Amortization 1.79B 4.67B 3.99B 7.04B
Interest Income 71.89M 62.32M 233.47M 153.28M
Other Income - Net 516.95M 261.30M 302.79M 1.01B
Special Income / Charges -122.63M -780.62M -330.76M -1.48B
Total Income Before Interest Expenses (EBIT) 7.12B 6.19B 7.54B 7.09B
Interest Expense 976.82M 486.52M 727.18M 840.95M
Pre-Tax Income 6.14B 5.71B 6.82B 6.25B
Income Taxes 1.40B 775.15M 1.48B 1.00B
Minority Interest 96.20M 110.42M 144.71M 218.18M
Net Income From Continuing Operations 4.74B 4.93B 5.34B 5.24B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.74B 4.93B 5.34B 5.24B
Extraordinary Income/Losses 331.95M -135.57M 142.27M 106.33M
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.98B 4.69B 5.34B 5.13B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.79B 6.58B 6.16B 7.14B
Preferred Dividends
Net Income Available To Common 0.00 4.93B 5.34B 5.24B
Basic EPS from Continuing Ops. 1.81 1.85 1.97 1.90
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.81 1.85 1.97 1.90
Basic EPS from Extraordinary Inc. 0.13 -0.05 0.05 0.04
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.93 1.79 2.03 1.94
Basic Normalized Net Income/Share 2.21 2.46 2.28 2.59
EPS fr Continuing Ops. 1.81 1.83 1.95 1.88
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.81 1.83 1.95 1.88
EPS fr Extraord. Inc. 0.13 -0.05 0.05 0.04
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.93 1.78 2.01 1.91
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.21 2.44 2.25 2.56
Dividends Paid per Share 1.66 1.61 1.91 1.86

Portfolios with SNY

Latest SNY Headlines from TheStreet

More Financial News for SNY

Press Releases for SNY

See All Press Releases

Partner Headlines for SNY

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter